These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 8717408)

  • 1. Toward selective elicitation of TH1-controlled vaccination responses: vaccine applications of bacterial surface layer proteins.
    Jahn-Schmid B; Messner P; Unger FM; Sleytr UB; Scheiner O; Kraft D
    J Biotechnol; 1996 Jan; 44(1-3):225-31. PubMed ID: 8717408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of experimental carbohydrate-conjugate vaccines composed of Streptococcus pneumoniae capsular polysaccharides and the universal helper T-lymphocyte epitope (PADRE).
    Alexander J; del Guercio MF; Frame B; Maewal A; Sette A; Nahm MH; Newman MJ
    Vaccine; 2004 Jun; 22(19):2362-7. PubMed ID: 15193395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Idiotypic vaccination for B-cell malignancies as a model for therapeutic cancer vaccines: from prototype protein to second generation vaccines.
    Ruffini PA; Neelapu SS; Kwak LW; Biragyn A
    Haematologica; 2002 Sep; 87(9):989-1001. PubMed ID: 12217812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-12 enhances antibody responses to T-independent polysaccharide vaccines in the absence of T and NK cells.
    Buchanan RM; Arulanandam BP; Metzger DW
    J Immunol; 1998 Nov; 161(10):5525-33. PubMed ID: 9820529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and immunogenicity of haemophilus influenzae type B polysaccharide or conjugate vaccines in an elderly adult population.
    Lottenbach KR; Granoff DM; Barenkamp SJ; Powers DC; Kennedy D; Irby-Moore S; Homan SM; Mink CM
    J Am Geriatr Soc; 2004 Nov; 52(11):1883-7. PubMed ID: 15507066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccinations with T-helper type 1 directing adjuvants have different suppressive effects on the development of allergen-induced T-helper type 2 responses.
    Trujillo-Vargas CM; Mayer KD; Bickert T; Palmetshofer A; Grunewald S; Ramirez-Pineda JR; Polte T; Hansen G; Wohlleben G; Erb KJ
    Clin Exp Allergy; 2005 Aug; 35(8):1003-13. PubMed ID: 16120081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antitumor vaccination: where we stand.
    Bocchia M; Bronte V; Colombo MP; De Vincentiis A; Di Nicola M; Forni G; Lanata L; Lemoli RM; Massaia M; Rondelli D; Zanon P; Tura S
    Haematologica; 2000 Nov; 85(11):1172-206. PubMed ID: 11074658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccination with a DNA vaccine based on human PSCA and HSP70 adjuvant enhances the antigen-specific CD8+ T-cell response and inhibits the PSCA+ tumors growth in mice.
    Zhang X; Yu C; Zhao J; Fu L; Yi S; Liu S; Yu T; Chen W
    J Gene Med; 2007 Aug; 9(8):715-26. PubMed ID: 17595048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The collaboration of both humoral and cellular HER-2/neu-targeted immune responses is required for the complete eradication of HER-2/neu-expressing tumors.
    Reilly RT; Machiels JP; Emens LA; Ercolini AM; Okoye FI; Lei RY; Weintraub D; Jaffee EM
    Cancer Res; 2001 Feb; 61(3):880-3. PubMed ID: 11221874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bacterial ghosts as multifunctional vaccine particles.
    Szostak MP; Mader H; Truppe M; Kamal M; Eko FO; Huter V; Marchart J; Jechlinger W; Haidinger W; Brand E; Denner E; Resch S; Dehlin E; Katinger A; Kuen B; Haslberger A; Hensel A; Lubitz W
    Behring Inst Mitt; 1997 Feb; (98):191-6. PubMed ID: 9382740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccine adjuvant systems containing monophosphoryl lipid A and QS21 induce strong and persistent humoral and T cell responses against hepatitis B surface antigen in healthy adult volunteers.
    Vandepapelière P; Horsmans Y; Moris P; Van Mechelen M; Janssens M; Koutsoukos M; Van Belle P; Clement F; Hanon E; Wettendorff M; Garçon N; Leroux-Roels G
    Vaccine; 2008 Mar; 26(10):1375-86. PubMed ID: 18272264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An evaluation of the immunogenicity and protective responses to Brachyspira hyodysenteriae recombinant SmpB vaccination.
    Holden J; Coloe PJ; Smooker PM
    Vet Microbiol; 2008 Apr; 128(3-4):354-63. PubMed ID: 18068912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intranasal administration is an effective mucosal vaccine delivery route for self-adjuvanting lipid core peptides targeting the group A streptococcal M protein.
    Olive C; Sun HK; Ho MF; Dyer J; Horváth A; Toth I; Good MF
    J Infect Dis; 2006 Aug; 194(3):316-24. PubMed ID: 16826479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Manipulation of immune responses via particle-mediated polynucleotide vaccines.
    Swain WF; Macklin MD; Neumann G; McCabe DE; Drape R; Fuller JT; Widera G; McGregor M; Callan RJ; Hinshaw V
    Behring Inst Mitt; 1997 Feb; (98):73-8. PubMed ID: 9382772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pilin-based anti-Pseudomonas vaccines: latest developments and perspectives.
    Hahn H; Lane-Bell PM; Glasier LM; Nomellini JF; Bingle WH; Paranchych W; Smit J
    Behring Inst Mitt; 1997 Feb; (98):315-25. PubMed ID: 9382755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer vaccines: an update with special focus on ganglioside antigens.
    Bitton RJ; Guthmann MD; Gabri MR; Carnero AJ; Alonso DF; Fainboim L; Gomez DE
    Oncol Rep; 2002; 9(2):267-76. PubMed ID: 11836591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Humoral immunity to viral and bacterial antigens in lymphoma patients 4-10 years after high-dose therapy with ABMT. Serological responses to revaccinations according to EBMT guidelines.
    Nordøy T; Husebekk A; Aaberge IS; Jenum PA; Samdal HH; Flugsrud LB; Kristoffersen AC; Holte H; Kvaløy S; Kolstad A
    Bone Marrow Transplant; 2001 Oct; 28(7):681-7. PubMed ID: 11704791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of antigen-specific immune responses by oral vaccination with Saccharomyces cerevisiae expressing Actinobacillus pleuropneumoniae ApxIIA.
    Shin SJ; Bae JL; Cho YW; Lee DY; Kim DH; Yang MS; Jang YS; Yoo HS
    FEMS Immunol Med Microbiol; 2005 Feb; 43(2):155-64. PubMed ID: 15681145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on immunity in mice immunized with outer membrane proteins of Hafnia.
    Witkowska D; Czarny A; Mulczyk M
    Arch Immunol Ther Exp (Warsz); 1992; 40(2):119-24. PubMed ID: 1299169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of T-cell immunity to oligosaccharide antigens immobilized on crystalline bacterial surface layers (S-layers).
    Smith RH; Messner P; Lamontagne LR; Sleytr UB; Unger FM
    Vaccine; 1993; 11(9):919-24. PubMed ID: 8212837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.